研究报告 |
|
|
|
|
shPLCε通过下调CDC25A抑制T24细胞的瓦伯格效应 * |
郝燕妮1,李婷1,范佳鑫1,李罗1,牛凌芳1,欧俐苹1,吴小候2,罗春丽1,**() |
1 重庆医科大学检验医学院 临床检验诊断学教育部重点实验室 重庆市重点实验室 重庆 400016 2 重庆医科大学附属第一医院 重庆 400016 |
|
Effects of shPLCε on Warburg Effect Through CDC25A in T24 Cells |
Yan-ni HAO1,Ting LI1,Jia-xin FAN1,Luo LI1,Ling-fang NIU1,Li-ping OU1,Xiao-hou WU2,Chun-li LUO1,**() |
1 Key Laboratory of Clinical Diagnostics Founded by Ministry of Education, College of Laboratory,Chongqing Medical University, Chongqing 400016, China 2 Department of Urinary Surgery, The First Affiliated Hospital of Chongqing, Medical University, Chongqing 400016, China |
引用本文:
郝燕妮,李婷,范佳鑫,李罗,牛凌芳,欧俐苹,吴小候,罗春丽. shPLCε通过下调CDC25A抑制T24细胞的瓦伯格效应 *[J]. 中国生物工程杂志, 2018, 38(5): 33-39.
Yan-ni HAO,Ting LI,Jia-xin FAN,Luo LI,Ling-fang NIU,Li-ping OU,Xiao-hou WU,Chun-li LUO. Effects of shPLCε on Warburg Effect Through CDC25A in T24 Cells. China Biotechnology, 2018, 38(5): 33-39.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20180505
或
https://manu60.magtech.com.cn/biotech/CN/Y2018/V38/I5/33
|
[1] |
Chen W, Zheng R, Baade P D , et al. Cancer statistics in China, 2015. CA: A Cancer Journal for Clinicians, 2016,66(2):115-132.
doi: 10.3322/caac.21338
|
[2] |
Warburg O . On the origin of cancer cells. Science, 1956,123(319):309-314.
doi: 10.1126/science.123.3191.309
|
[3] |
Vander Heiden M G, Cantley L C, Thompson C B . Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science, 2009,324(5930):1029-1033.
doi: 10.1126/science.1160809
|
[4] |
Henry J, Guillotte A, Luberto C , et al. Characterization of inositol phospho-sphingolipid-phospholipase C 1 (Isc1) in Cryptococcus neoformans reveals unique biochemical features. FEBS Lett, 2011,585(4):635-640.
doi: 10.1016/j.febslet.2011.01.015
pmid: 21256847
|
[5] |
赵燕, 郝燕妮, 刘南京 , 等. miR-145通过下调PLCε抑制膀胱癌EMT和迁移及其机制研究. 中国生物工程杂志, 2017,37(3):27-36.
|
|
Zhao Y, Hao Y N, Liu N J , et al. Sillence of PLCε induced by miR-145 inhibits EMT and metastasis in bladder cancer. China Biotechnology, 2017,37(3):27-36.
|
[6] |
Wind F, Negelein E . The metabolism of tumors in the body. Journal of General Physiology, 1927,8(6):519-530.
doi: 10.1085/jgp.8.6.519
pmid: 2140820
|
[7] |
Warburg O . Warburg OOn respiratory impairment in cancer cells. Science, 1956,124(3215):269-270.
|
[8] |
Cairns R A, Harris I S, Mak T W . Regulation of cancer cell metabolism. Nature Reviews Cancer, 2011,11(2):85-95.
doi: 10.1038/nrc2981
|
[9] |
Cantor J R, Sabatini D M . Cancer cell metabolism: one hallmark, many faces. Cancer Discovery, 2012,2(10):881.
doi: 10.1158/2159-8290.CD-12-0345
pmid: 3491070
|
[10] |
Hicks S N, Jezyk M R, Gershburg S , et al. General and versatile autoinhibition of PLC isozymes. Mol Cell, 2008,31(3):383-394.
doi: 10.1016/j.molcel.2008.06.018
pmid: 18691970
|
[11] |
Wing M R, Snyder J T, Sondek J , et al. Direct activation of phospholipase C-epsilon by Rho. J Biol Chem, 2003,278(42):41253-41258.
doi: 10.1074/jbc.M306904200
pmid: 12900402
|
[12] |
Abnet C C, Freedman N D, Hu N , et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nature Genetics, 2010,42(9):764-776.
doi: 10.1038/ng.649
pmid: 20729852
|
[13] |
Smrcka A V, Brown J H, Holz G G . Role of phospholipase Cε in physiological phosphoinositide signaling networks. Cellular Signalling, 2012,24(6):1333.
doi: 10.1016/j.cellsig.2012.01.009
|
[14] |
Alfarouk K O, Verduzco D, Rauch C , et al. Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question. Oncoscience, 2014,1(12):777-802.
doi: 10.18632/oncoscience.109
pmid: 4468317
|
[15] |
Kim J, Dang C V . Cancer’s molecular sweet tooth and the Warburg effect. Cancer Research, 2006,66(18):8927.
doi: 10.1158/0008-5472.CAN-06-1501
pmid: 16982728
|
[16] |
Jinno S, Suto K, Nagata A , et al. Cdc25A is a novel phosphatase functioning early in the cell cycle. Embo Journal, 1994,13(7):1549-1556.
doi: 10.1002/j.1460-2075.1994.tb06417.x
pmid: 8156993
|
[17] |
Kang T, Wei Y, Honaker Y , et al. GSK-3β targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3β inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell, 2008,13(1):36-47.
doi: 10.1016/j.ccr.2007.12.002
pmid: 2276649
|
[18] |
Ji L, Cao R, Zhang Y , et al. PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis. Nature Communications, 2016,7:12431.
doi: 10.1038/ncomms12431
pmid: 27485204
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|